- $441.39m
- $421.55m
- $26.33m
Annual cashflow statement for NVE, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14.5 | 22.7 | 17.1 | 15.1 | 15.2 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.082 | 0.06 | 0.045 | -0.217 | -0.116 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.54 | -4.08 | 1.77 | -0.25 | -0.99 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | 12.5 | 19.1 | 18.2 | 14.3 | 16.7 |
| Capital Expenditures | -0.485 | -0.936 | -0.017 | -1.26 | -2.19 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 7.5 | -7.59 | 9.6 | 3.93 | -1.44 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 7.02 | -8.53 | 9.58 | 2.67 | -3.63 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | -19.5 | -19.3 | -19.2 | -19.2 | -19.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.022 | -8.78 | 8.61 | -2.25 | -6.32 |